Literature DB >> 26872246

Fetal cardiovascular hemodynamics in twin-twin transfusion syndrome.

Christoph Wohlmuth1,2, Helena M Gardiner1, Werner Diehl3, Kurt Hecher3.   

Abstract

Twin-twin transfusion syndrome (TTTS) complicates 10-15% of monochorionic-diamniotic (MCDA) pregnancies. It originates from unbalanced transfer of fluid and vasoactive mediators from one twin to its co-twin via placental anastomoses. This results in hypovolemia in the donor and hypervolemia and vasoconstriction in the recipient twin. Consequently, the recipient demonstrates cardiovascular alterations including atrioventricular valve regurgitation, diastolic dysfunction, and pulmonary stenosis/atresia that do not necessarily correlate with Quintero-stages. Selective fetoscopic laser photocoagulation of placental vascular anastomoses disrupts the underlying pathophysiology and usually improves cardiovascular function in the recipient with normalization of systolic and diastolic function within weeks after treatment. Postnatal studies have demonstrated early decreased arterial distensibility in ex-donor twins, but 10-year follow up is encouraging with survivors showing normal cardiovascular function after TTTS. However, prediction and appropriate early management of TTTS remain poor. Assessment of the cardiovascular system provides additional insight into the pathophysiology and severity of TTTS and may permit more targeted early surveillance of MCDA pregnancies in future. It should form an integral part of the diagnostic algorithm.
© 2016 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Cardiovascular physiology; monochorionic twins; multifetal gestation; twin-twin transfusion syndrome

Mesh:

Year:  2016        PMID: 26872246     DOI: 10.1111/aogs.12871

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  7 in total

1.  Measurement of cardiac function by cardiac time intervals, applicability in normal pregnancy and twin-to-twin transfusion syndrome.

Authors:  S J Eschbach; M Gijtenbeek; N van Geloven; D Oepkes; M C Haak
Journal:  J Echocardiogr       Date:  2018-10-20

2.  Amniotic fluid microRNA profiles in twin-twin transfusion syndrome with and without severe recipient cardiomyopathy.

Authors:  Emily C Willner; Henry L Galan; Bettina F Cuneo; Hilary A Hoffman; Bonnie Neltner; Eleanor L Schuchardt; Anis Karimpour-Fard; Shelley D Miyamoto; Carmen C Sucharov
Journal:  Am J Obstet Gynecol       Date:  2021-06-19       Impact factor: 10.693

Review 3.  Fetal cardiovascular alterations in twin-to-twin transfusion syndrome.

Authors:  Ioana Cristina Rotar; Gabriela Zaharie; Adelina Staicu; Andreia Preda; Daniel Mureşan
Journal:  Med Pharm Rep       Date:  2020-01-31

4.  Fetal ventricular strain in uncomplicated and selective growth-restricted monochorionic diamniotic twin pregnancies and cardiovascular response in pre-twin-twin transfusion syndrome.

Authors:  C Wohlmuth; A Agarwal; B Stevens; A Johnson; K J Moise; R Papanna; R Donepudi; C S Bell; I E Averiss; H M Gardiner
Journal:  Ultrasound Obstet Gynecol       Date:  2020-11       Impact factor: 7.299

5.  Amniotic Fluid microRNA in Severe Twin-Twin Transfusion Syndrome Cardiomyopathy-Identification of Differences and Predicting Demise.

Authors:  Eleanor L Schuchardt; Shelley D Miyamoto; Timothy Crombleholme; Anis Karimpour-Fard; Armin Korst; Bonnie Neltner; Lisa W Howley; Bettina Cuneo; Carmen C Sucharov
Journal:  J Cardiovasc Dev Dis       Date:  2022-01-23

6.  Cardiac time intervals and myocardial performance index for prediction of twin-twin transfusion syndrome.

Authors:  Manon Gijtenbeek; Sanne J Eschbach; Johanna M Middeldorp; Frans J C M Klumper; Femke Slaghekke; Dick Oepkes; Monique C Haak
Journal:  Prenat Diagn       Date:  2021-06-17       Impact factor: 3.242

7.  Twin-twin transfusion syndrome: don't rely on fluids and bladders to catch it early.

Authors:  C Wohlmuth; H M Gardiner
Journal:  Ultrasound Obstet Gynecol       Date:  2022-01       Impact factor: 8.678

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.